Apigenin vs. Quercetin: How Two Common Flavonoids Differ in Mechanism and Potential Use

Apigenin and quercetin are among the most studied plant flavonoids, yet they belong to different flavonoid subclasses, appear in different foods, and interact with the body through partly distinct pathways. Understanding how they differ — and where they overlap — can help you make a more informed choice if you are considering either as a dietary supplement.

Both compounds are found naturally in fruits, vegetables, and herbs, and both have attracted scientific attention for antioxidant, anti-inflammatory, and potential anticancer properties. Neither is a medicine, and neither should be treated as one. What follows is an honest summary of what current research does and does not support.

Chemical Structure: Flavone vs. Flavonol

Apigenin (4′,5,7-trihydroxyflavone) is a flavone — a subclass defined by a double bond between carbons 2 and 3 and no hydroxyl group at the 3-position. Quercetin is a flavonol, which shares the same double bond but adds a hydroxyl group at C-3. That single structural difference has meaningful downstream effects on how each molecule behaves chemically and biologically.

Quercetin’s extra hydroxyl group gives it a greater number of electron-donation sites, which helps explain why it consistently scores well in antioxidant assays ^[6]. Apigenin has fewer hydroxyl groups but achieves high affinity at specific protein targets — most notably benzodiazepine-binding sites on GABA-A receptors — that quercetin does not engage as strongly. In flavonoid biology, structure is closely tied to function.

Antioxidant and Anti-inflammatory Activity

Quercetin is widely regarded as one of the most potent antioxidant flavonoids in routine dietary sources, regularly ranking near the top of comparative radical-scavenging assays ^[6]. Its ability to quench reactive oxygen and nitrogen species has been examined across multiple cell models; different dietary flavonoids produce meaningfully different antioxidant enzyme responses in human liver cells challenged with proinflammatory cytokines, underscoring that flavonoids are not interchangeable despite sharing a core scaffold ^[2].

Apigenin’s anti-inflammatory activity is well-documented in endothelial research. In cultured human endothelial cells stimulated with TNF-alpha, flavones — apigenin being the prototype — suppressed the upregulation of adhesion molecules ICAM-1 and VCAM-1 through inhibition of NF-kB signaling ^[1]. This pathway is relevant to vascular inflammation, though findings in cell culture do not automatically translate to clinical benefit. Quercetin demonstrates related NF-kB modulation and additionally acts as a zinc ionophore, a property apigenin does not share.

In practical terms, quercetin appears to offer broader radical-scavenging coverage, while apigenin targets specific inflammatory signaling nodes with greater selectivity. Flavonoid glycosides more broadly have demonstrated antioxidant activity across botanical sources ^[3], reinforcing that both aglycone and glycoside forms contribute to overall dietary antioxidant load. Neither profile is inherently superior; the more relevant compound depends on which biological context is being considered.

Cancer Research: Shared Interest, Different Mechanisms

Both flavonoids have been studied extensively in preclinical cancer models. Apigenin’s best-characterized anticancer mechanism involves inhibition of cyclin-dependent kinases CDK2 and CDK6, which are required for cell-cycle progression. By stalling this checkpoint, apigenin can push certain cancer cell lines toward apoptosis. Research examining apigenin’s role in skin inflammatory diseases and cancer suggests it modulates multiple intracellular targets, positioning it as a candidate for ongoing investigation ^[8].

Quercetin’s anticancer activity spans multiple signaling pathways including PI3K/Akt and MAPK. Both quercetin and apigenin appear together in plants examined for digestive cancer prevention — Portulaca oleracea (purslane), which contains both compounds, has been studied in models of gastrointestinal inflammatory cancer transformation ^[11]. Mediterranean dietary polyphenols, quercetin among them, have also been associated in observational data with reduced colorectal cancer risk, though establishing causation from dietary cohort studies remains methodologically difficult ^[7].

Flavonoid-modulated JAK-STAT signaling is another pathway under active investigation for its relevance to malignant transformation and drug resistance in breast tumors, with quercetin and related compounds demonstrating activity at this node ^[12]. Nano-encapsulation strategies are being explored for both compounds to improve bioavailability and targeted delivery, given that raw oral bioavailability of most polyphenols is limited ^{[10] [5]}. All of this research is preclinical or early-stage; neither compound is an approved cancer treatment.

NAD+ and Metabolic Support: An Apigenin-Specific Angle

One area where apigenin has drawn particular recent attention is NAD+ metabolism. CD38, an enzyme that degrades NAD+, is one of the primary routes through which NAD+ levels decline with age. Apigenin has been identified as a modest inhibitor of CD38 activity, prompting interest in whether dietary or supplemental apigenin could help sustain NAD+ availability and thereby support mitochondrial function ^[9].

Quercetin has also been examined in the context of NAD+ pathways, though its primary mechanistic entry point differs from apigenin’s CD38-focused activity ^[9]. Research on both compounds here remains early-stage, and human dosing data sufficient to guide supplementation are not yet well-established. Claims that either flavonoid reliably raises NAD+ levels in healthy adults to a clinically meaningful degree are not currently supported by robust clinical trial evidence.

Neurological and Sleep-Related Effects

Apigenin is unusual among common dietary flavonoids in its affinity for benzodiazepine-binding sites on GABA-A receptors. GABA-A receptor activation promotes inhibitory neurotransmission, which underlies the anxiolytic and sedative profile long associated with chamomile — apigenin’s richest dietary source. This receptor-binding mechanism is part of why apigenin has been studied in the context of sleep onset and anxiety.

Quercetin does not share this GABA-A receptor affinity to the same degree. It has been explored for neuroprotective effects through antioxidant and anti-inflammatory pathways, but it lacks the discrete GABAergic sedative mechanism that distinguishes apigenin. For individuals specifically interested in sleep-support applications, apigenin has a more clearly defined proposed mechanism.

Because apigenin acts at benzodiazepine receptor sites, combining it with other GABAergic compounds — including benzodiazepine medications, alcohol, and melatonin — could produce additive sedation. Individuals taking prescription sedatives or anxiolytics should consult a physician before adding apigenin.

Dietary Sources and Food Distribution

Apigenin is most concentrated in chamomile, parsley, and celery, where it exists partly as the glycoside apigenin-7-glucoside. It also appears in minor quantities in white tea; metabolomics profiling of white, green, and black teas has confirmed substantial variation in flavonoid compound profiles depending on processing method ^[4].

Quercetin is more widely distributed across the plant kingdom. Onions — particularly red onions — are among the richest sources, and significant amounts also appear in capers, apples, broccoli, and buckwheat. Because of this wider distribution, average dietary quercetin intake is typically higher than apigenin intake in populations consuming Western diets. Both compounds appear as glycosides in whole foods and are hydrolyzed to their aglycone forms during digestion, a conversion that affects absorption and bioavailability.

A Note on the Evidence

The evidence for both apigenin and quercetin is largely preclinical — drawn from cell culture and animal studies — and robust human clinical trials establishing effective doses, long-term safety, or confirmed health outcomes remain limited; apigenin in particular inhibits CYP1A2, CYP2C9, and CYP3A4 and acts at GABA-A benzodiazepine sites, so individuals taking warfarin, certain statins, benzodiazepines, melatonin, or alcohol should consult a physician before supplementing, and these statements have not been evaluated by the FDA — neither compound is intended to diagnose, treat, cure, or prevent any disease.

Frequently Asked Questions

Which is a stronger antioxidant, apigenin or quercetin?

In direct comparative assays, quercetin typically demonstrates greater radical-scavenging activity, attributable in part to its additional hydroxyl group at C-3 ^[6]. Apigenin’s antioxidant capacity is real but narrower; it is more notable for targeted anti-inflammatory signaling than for broad electron donation. Which compound is ‘stronger’ depends on the specific biological endpoint being measured.

Can apigenin and quercetin be taken together?

There is no well-established clinical evidence on combined supplementation. Because both inhibit certain CYP450 enzymes — apigenin notably CYP1A2, CYP2C9, and CYP3A4 — combining them could theoretically amplify drug-interaction risks for anyone on prescription medications. Consult a physician before stacking either with pharmaceutical drugs, particularly warfarin, certain statins, or benzodiazepines.

Does apigenin help with sleep in a way quercetin does not?

Apigenin binds benzodiazepine sites on GABA-A receptors, providing a proposed mechanism for sleep onset and anxiolysis that quercetin does not share to the same degree. This GABAergic activity is why chamomile — rich in apigenin — has a long folk history as a calming herb. Caution is warranted when combining apigenin with other sedatives, including alcohol and prescription anxiolytics, due to the risk of additive sedation.

Are either of these flavonoids useful against cancer?

Both have shown activity against cancer cell lines and tumor models in preclinical studies through mechanisms including CDK inhibition (apigenin), JAK-STAT modulation ^[12], and NF-kB suppression ^[1]. Nano-formulations are being explored to improve delivery to tumor cells ^[10]. Neither is an approved cancer treatment, and preclinical results cannot be assumed to translate directly to humans.

What foods are the best sources of each?

Apigenin is most concentrated in chamomile, parsley, and celery; it also appears in white tea, where flavonoid profiles vary substantially by processing method ^[4]. Quercetin is more broadly distributed: onions, capers, apples, and buckwheat are particularly rich sources. For most people following a Western diet, quercetin intake from food is likely higher than apigenin intake.

Do apigenin and quercetin both support NAD+ levels?

Apigenin has been identified as a CD38 inhibitor — a proposed mechanism for supporting NAD+ availability — and quercetin has been investigated in related NAD+ metabolism pathways as well ^[9]. Both relationships remain at an early research stage. There is insufficient human clinical trial data to make firm dosing or efficacy claims for either compound in this context, and neither should be used as a replacement for established NAD+ precursors with stronger clinical backing.

References

1. Choi JS et al. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. The Journal of nutrition (2004). PMID 15113938
2. Crespo I et al. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2008). PMID 18234413
3. Taiwo BJ et al. Antioxidant and antibacterial activities of flavonoid glycosides from Ficus exasperata Vahl-Holl (moraceae) leaves. African journal of traditional, complementary, and alternative medicines : AJTCAM (2014). PMID 25371569
4. Dai W et al. Characterization of white tea metabolome: Comparison against green and black tea by a nontargeted metabolomics approach. Food research international (Ottawa, Ont.) (2017). PMID 28528106
5. Khan H et al. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Seminars in cancer biology (2021). PMID 31374244
6. Guzelmeric E et al. Comparison of antioxidant and anti-inflammatory activity profiles of various chemically characterized Turkish propolis sub-types: Which propolis type is a promising source for pharmaceutical product development?. Journal of pharmaceutical and biomedical analysis (2021). PMID 34119836
7. Yammine A et al. Polyphenols of the Mediterranean Diet and Their Metabolites in the Prevention of Colorectal Cancer. Molecules (Basel, Switzerland) (2021). PMID 34201125
8. Yoon JH et al. Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer. International journal of molecular sciences (2023). PMID 36675015
9. Guo C et al. Therapeutic application of natural products: NAD(+) metabolism as potential target. Phytomedicine : international journal of phytotherapy and phytopharmacology (2023). PMID 36948143
10. Yıldırım M et al. Recent Strategies for Cancer Therapy: Polymer Nanoparticles Carrying Medicinally Important Phytochemicals and Their Cellular Targets. Pharmaceutics (2023). PMID 38004545
11. Shao G et al. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug. Journal of ethnopharmacology (2024). PMID 38447616
12. Kubatka P et al. Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation. Journal of advanced research (2026). PMID 41205803

These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.